ReviewTranslational cancer research2023

A narrative review about CDK4/6 inhibitors in the setting of drug resistance: updates on biomarkers and therapeutic strategies in breast cancer.

Shidi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.